A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer (Q35034708)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q92576217)
(Q55975497)
(P304) 1828-1835
(P407) (Q1860)
(P433) 12
(P478) 104
(P577) Tuesday, May 10, 2011
(P921) (Q181600)
(Q412178)
(Q128581)
(P1433) (Q326309)
(P1476) "A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer" (language: en)
(P2093) P N Munster
K T Thurn
S Thomas
P Raha
M Lacevic
A Miller
R Ismail-Khan
M Moasser
S E Minton
(P2860) (Q37141408)
(Q34781067)
(Q27860525)
(Q37400592)
(Q36285977)
(Q24316879)
(Q34968336)
(Q33383828)
(Q36528653)
(Q40002231)
(Q24320333)
(Q40093675)
(Q40191002)
(Q40195308)
(Q24681480)
(Q40266897)
(Q33369463)
(Q35758280)
(Q29547513)
(Q38443324)
(Q40483284)
(Q40607139)
(Q33356908)
(Q27860904)
(Q43824354)
(Q52231249)
(Q46720989)
(Q44594527)
(Q43755864)
(Q43607761)
(Q73190394)
(Q79834346)
(Q80358623)
other details
description scientific article

External Links